Shifeng Lou

637 total citations
27 papers, 331 citations indexed

About

Shifeng Lou is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Shifeng Lou has authored 27 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Hematology and 6 papers in Oncology. Recurrent topics in Shifeng Lou's work include Acute Myeloid Leukemia Research (7 papers), Hematopoietic Stem Cell Transplantation (4 papers) and RNA Interference and Gene Delivery (3 papers). Shifeng Lou is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Hematopoietic Stem Cell Transplantation (4 papers) and RNA Interference and Gene Delivery (3 papers). Shifeng Lou collaborates with scholars based in China, United States and United Kingdom. Shifeng Lou's co-authors include Nan Zhang, Yan Shen, Huan Li, Ying Chen, Ping Zhang, Li Gao, Hanqing Zeng, Peiyan Kong, Lei Gao and Jia Liu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Biochemical and Biophysical Research Communications.

In The Last Decade

Shifeng Lou

24 papers receiving 328 citations

Peers

Shifeng Lou
Vitina Grieco Italy
Zhongxing Jiang China
Liya Ma China
Susumu Kirimura Japan
Maria Antonella Laginestra Italy
Ashley Ringrose Canada
David Stroncek United States
Valentina Bozzoli Italy
Diego Quinones Raffo United States
Vitina Grieco Italy
Shifeng Lou
Citations per year, relative to Shifeng Lou Shifeng Lou (= 1×) peers Vitina Grieco

Countries citing papers authored by Shifeng Lou

Since Specialization
Citations

This map shows the geographic impact of Shifeng Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shifeng Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shifeng Lou more than expected).

Fields of papers citing papers by Shifeng Lou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shifeng Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shifeng Lou. The network helps show where Shifeng Lou may publish in the future.

Co-authorship network of co-authors of Shifeng Lou

This figure shows the co-authorship network connecting the top 25 collaborators of Shifeng Lou. A scholar is included among the top collaborators of Shifeng Lou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shifeng Lou. Shifeng Lou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Ying, Zhe Chen, Ping Zhang, et al.. (2025). Mitoxantrone-liposome Sensitizes FLT3-ITD Acute Myeloid Leukemia to Gilteritinib Treatment. Journal of Cancer. 16(6). 1905–1917. 1 indexed citations
2.
Liu, Luyao, Shifeng Lou, Dong Fu, et al.. (2025). Neuro-immune interactions: Exploring the anti-inflammatory role of the vagus nerve. International Immunopharmacology. 159. 114941–114941. 3 indexed citations
3.
4.
Chen, Yiwen, et al.. (2025). Design and development of an aptamer targeting C-type lectin-like molecule-1 as a biomarker for acute myeloid leukemia: a SELEX approach. Frontiers in Bioengineering and Biotechnology. 13. 1601453–1601453.
5.
6.
Liu, Yue, et al.. (2024). Afatinib boosts CAR-T cell antitumor therapeutic efficacy via metabolism and fate reprogramming. Journal for ImmunoTherapy of Cancer. 12(11). e009949–e009949. 5 indexed citations
7.
Zhang, Yanfang, Ying Zhang, Hanqing Zeng, et al.. (2023). Decreased lymphocyte count before conditioning is associated with BK virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation. International Immunopharmacology. 121. 110515–110515. 2 indexed citations
8.
9.
Zhang, Nan, Yan Shen, Huan Li, et al.. (2022). The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability. Experimental & Molecular Medicine. 54(2). 194–205. 85 indexed citations
10.
Li, Yifei, Wu Wu, Jingwen Zhou, et al.. (2022). The hsa-miR-214-3p/ATGL axis regulates aberrant lipolysis to promote acute myeloid leukemia progression via PPARα in vitro. Biochemical and Biophysical Research Communications. 608. 73–81. 6 indexed citations
11.
Zhang, Ping, et al.. (2021). Development of a Prognostic Nomogram for Acute Myeloid Leukemia on IGHD Gene Family. International Journal of General Medicine. Volume 14. 4303–4316. 2 indexed citations
12.
Shen, Yan, et al.. (2021). Feasibility of therapeutic plasma exchange-based combination therapy in the treatment of acquired hemophilia A. Medicine. 100(29). e26587–e26587. 1 indexed citations
13.
14.
Zhang, Nan, Ying Zhang, Ping Zhang, et al.. (2020). Overexpression of annexin A5 might guide the gemtuzumab ozogamicin treatment choice in patients with pediatric acute myeloid leukemia. Therapeutic Advances in Medical Oncology. 12. 3863542675–3863542675. 6 indexed citations
15.
Li, Jiali, Sanbin Wang, Yicheng Zhang, et al.. (2020). Is It Better to Mobilize Hematopoietic Stem Cells With Pegfilgrastim in Healthy Donors During Allogeneic Hematopoietic Stem Cell Transplantation?. Frontiers in Oncology. 10. 1598–1598. 6 indexed citations
16.
Zhang, Nan, et al.. (2019). <p>A six-gene-based prognostic model predicts complete remission and overall survival in childhood acute myeloid leukemia</p>. OncoTargets and Therapy. Volume 12. 6591–6604. 18 indexed citations
17.
Zhang, Nan, et al.. (2019). Comprehensive analysis the potential biomarkers for the high-risk of childhood acute myeloid leukemia based on a competing endogenous RNA network. Blood Cells Molecules and Diseases. 79. 102352–102352. 15 indexed citations
18.
19.
20.
Luo, Yun, et al.. (2015). Ginsenoside Rg3 induces apoptosis in human multiple myeloma cells via the activation of Bcl-2-associated X protein. Molecular Medicine Reports. 12(3). 3557–3562. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vitina Grieco Breakdown of academic impact, for papers by Zhongxing Jiang Breakdown of academic impact, for papers by Liya Ma Breakdown of academic impact, for papers by Susumu Kirimura Breakdown of academic impact, for papers by Maria Antonella Laginestra Breakdown of academic impact, for papers by Ashley Ringrose Breakdown of academic impact, for papers by David Stroncek Breakdown of academic impact, for papers by Valentina Bozzoli Breakdown of academic impact, for papers by Diego Quinones Raffo
Rankless by CCL
2026